CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-21 | Bitterman Robert J Chairman, Pres & CEO | Purchase | +3,000 | $1.77 | $5K | 22,449 |
| 2025-05-20 | Ferrara Robert L Director | Purchase | +2,500 | $1.82 | $5K | 13,166 |
| 2024-09-11 | Infarinato Robert M. VP, CFO | Grant or award | +3,000 | 11,000 | ||
| 2024-09-11 | Freeman Jonathan E Director | Grant or award | +1,000 | 1,000 | ||
| 2024-09-11 | Bitterman Robert J Chairman, Pres & CEO | Grant or award | +15,500 | 17,832 | ||
| 2024-09-11 | Lockshin Curtis Director | Grant or award | +2,000 | 2,000 | ||
| 2024-09-11 | Ferrara Robert L Director | Grant or award | +10,000 | 10,000 | ||
| 2024-09-11 | BRADFORD PATRICIA A Director | Grant or award | +8,000 | 8,000 | ||
| 2024-08-13 | Infarinato Robert M. VP, Chief Financial Officer | Grant or award | +8,000 | 8,000 | ||
| 2024-06-07 | Bitterman Robert J President & CEO | Purchase | +1,000 | $0.74 | $740 | 20,990 |
| 2024-06-06 | Bitterman Robert J President & CEO | Purchase | +1,000 | $0.75 | $750 | 19,990 |
| 2024-03-01 | Kontulis Caitlin Secretary & VP Finance & Admin | Shares withheld for taxes | −335 | $0.96 | $321 | 10,643 |
| 2024-02-26 | Bitterman Robert J President & CEO | Purchase | +2,500 | $0.91 | $2K | 18,990 |
| 2024-02-20 | Bitterman Robert J President & CEO | Shares withheld for taxes | −1,804 | $0.76 | $1K | 16,490 |
| 2024-02-17 | Kontulis Caitlin Secretary & VP Finance & Admin | Shares withheld for taxes | −523 | $0.66 | $345 | 10,978 |
| 2024-02-15 | Kontulis Caitlin Secretary & VP Finance & Admin | Shares withheld for taxes | −658 | $0.65 | $428 | 11,501 |
| 2023-10-01 | Bitterman Robert J President & CEO | Shares withheld for taxes | −917 | $1.51 | $1K | 18,294 |
| 2023-07-01 | Bitterman Robert J President & CEO | Purchase | +1,000 | $2.84 | $3K | 19,211 |
| 2023-06-30 | Bitterman Robert J President & CEO | Purchase | +1,000 | $2.88 | $3K | 18,211 |
| 2023-06-14 | Ferrara Robert L Director | Purchase | +2,000 | $3.10 | $6K | 6,000 |
Page 3 of 6 · 112 trades